Cyclacel Pharmaceuticals Preferred Stock Analysis
| CYCCP Preferred Stock | USD 5.80 0.04 0.69% |
Cyclacel Pharmaceuticals is overvalued with Real Value of 5.22 and Hype Value of 5.8. The main objective of Cyclacel Pharmaceuticals preferred stock analysis is to determine its intrinsic value, which is an estimate of what Cyclacel Pharmaceuticals is worth, separate from its market price. There are two main types of Cyclacel Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Cyclacel Pharmaceuticals preferred stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Cyclacel |
Cyclacel Preferred Stock Analysis Notes
The company recorded a loss per share of 2.05. Cyclacel Pharmaceuticals last dividend was issued on the 12th of January 2023. The entity had 1:12 split on the 31st of May 2016. Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Cyclacel Pharmaceuticals please contact Spiro Rombotis at 908 517 7330 or go to https://www.cyclacel.com.Cyclacel Pharmaceuticals Investment Alerts
| Cyclacel Pharmaceuticals generated a negative expected return over the last 90 days | |
| Cyclacel Pharmaceuticals has high historical volatility and very poor performance | |
| Cyclacel Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (18.89 M) with loss before overhead, payroll, taxes, and interest of (338 K). | |
| Cyclacel Pharmaceuticals has accumulated about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32. |
Cyclacel Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cyclacel Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Cyclacel Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 14th of December 2024, Cyclacel Pharmaceuticals shows the risk adjusted performance of (0.06), and Mean Deviation of 2.27. Cyclacel Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cyclacel Pharmaceuticals Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cyclacel Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cyclacel Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Cyclacel Pharmaceuticals Outstanding Bonds
Cyclacel Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cyclacel Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cyclacel bonds can be classified according to their maturity, which is the date when Cyclacel Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Cyclacel Pharmaceuticals Predictive Daily Indicators
Cyclacel Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cyclacel Pharmaceuticals preferred stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cyclacel Pharmaceuticals Forecast Models
Cyclacel Pharmaceuticals' time-series forecasting models are one of many Cyclacel Pharmaceuticals' preferred stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cyclacel Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cyclacel Preferred Stock Analysis
Preferred Stock analysis is the technique used by a trader or investor to examine and evaluate how Cyclacel Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cyclacel shares will generate the highest return on investment. We also built our preferred stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Preferred Stock such as Cyclacel Pharmaceuticals. By using and applying Cyclacel Preferred Stock analysis, traders can create a robust methodology for identifying Cyclacel entry and exit points for their positions.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey. Cyclacel Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our preferred stock analysis tools, you can find out how much better you can do when adding Cyclacel Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.